Improving resource mobilisation for global health R&D: a role for coordination platforms?

Abstract

Achieving many of the health targets in the Sustainable Development Goals will not be possible without increased financing for global health research and development (R&D). Yet financing for neglected disease product development fell from 2009-2015, with the exception of a one-time injection of Ebola funding. An important cause of the global health R&D funding gap is lack of coordination across R&D initiatives. In particular, existing initiatives lack robust priority-setting processes and transparency about investment decisions. Low-income countries (LICs) and middle-income countries (MICs) are also often excluded from global investment initiatives and priority-setting discussions, leading to limited investment by these countries. An overarching global health R&D coordination platform is one promising response to these challenges. This analysis examines the essential functions such a platform must play, how it should be structured to maximise effectiveness and investment strategies for diversifying potential investors, with an emphasis on building LIC and MIC engagement. Our analysis suggests that a coordination platform should have four key functions: building consensus on R&D priorities; facilitating information sharing about past and future investments; building in accountability mechanisms to track R&D spending against investment targets and curating a portfolio of prioritised projects alongside mechanisms to link funders to these projects. Several design features are likely to increase the platform’s success: public ownership and management; separation of coordination and financing functions; inclusion of multiple diseases; coordination across global and national efforts; development of an international R&D ‘roadmap’ and a strategy for the financial sustainability of the platform’s secretariat.

Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review

“…Scarcity of funding for research is a key constraint to needed implementation research for NCDs. While there are proposals for coordinating and increasing global support, it is unrealistic to expect this to meet the scale of needed research without a substantial increase in countries’ investment in research [ 255 ]. Such an investment is likely to pay off in better health and higher quality, more efficient service delivery [ 256 ].…”

Implementation Research in Nepal – A Scoping Review, 2015-2022

“…While global coordination and support are highly valued, it is unrealistic to expect the high scale of the research without substantial countries' investment in research. 46 Resource scarcity for research is a key constraint to expand implementation research. To make the best use of the available resources, in-country implementation research needs to strive for generalizability and move to hybrid designs.…”

Reboot biomedical R&D in the global public interest

“…Countries that have the greatest burdens of neglected diseases, for example, have had little input. Instead, priorities are largely funded and decided by high-income country donors 8 . Furthermore, priority-setting requires 'gap analyses' of existing technologies and ongoing R&D. Such information, often opaque and fragmented, requires significant resources to gather and interpret.…”